Capsid and Genome Modification Strategies to Reduce the Immunogenicity of Adenoviral Vectors
Sign Up to like & getrecommendations! Published in 2021 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms22052417
Abstract: Adenovirus-based gene transfer vectors are the most frequently used vector type in gene therapy clinical trials to date, and they play an important role as genetic vaccine candidates during the ongoing SARS-CoV-2 pandemic. Immediately upon… read more here.
Keywords: genome modification; modification strategies; immunogenicity adenoviral; reduce immunogenicity ... See more keywords